Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
979
mi
from 98109
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at Los Angeles - UCLA
979
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
979
mi
from 98109
Los Angeles, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
VA Greater Los Angeles Healthcare System
979
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
704
mi
from 98109
Stanford, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1026
mi
from 98109
Aurora, CO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Colorado Cardiac and Vascular Center
1026
mi
from 98109
Aurora, CO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2709
mi
from 98109
Weston, FL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Florida
2709
mi
from 98109
Weston, FL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2180
mi
from 98109
Atlanta, GA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Emory Clinic
2180
mi
from 98109
Atlanta, GA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1737
mi
from 98109
Chicago, IL
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Chicago
1737
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1495
mi
from 98109
Kansas City, KA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Kansas Medical Center
1495
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2099
mi
from 98109
New Orleans, LA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Lsu Health Sciences Center
2099
mi
from 98109
New Orleans, LA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2328
mi
from 98109
Baltimore, MD
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Maryland Medical Center Division of Cardiology
2328
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2485
mi
from 98109
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Boston University Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2485
mi
from 98109
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2485
mi
from 98109
Boston, MA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1903
mi
from 98109
Ann Arbor, MI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Michigan
1903
mi
from 98109
Ann Arbor, MI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1388
mi
from 98109
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Abbott Northwestern Hospital
1388
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1393
mi
from 98109
Minneapolis, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2161
mi
from 98109
Rochester, NY
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Mary M Parkes Center
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2016
mi
from 98109
Cleveland, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Cleveland Clinic Foundation
2016
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2008
mi
from 98109
Columbus, OH
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Ohio State University Martha Morehouse Medical Pavilion
2008
mi
from 98109
Columbus, OH
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2131
mi
from 98109
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Allegheny General Hospital
2131
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2134
mi
from 98109
Pittsburgh, PA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of Pittsburgh
2134
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1682
mi
from 98109
Dallas, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
U.T. Southwestern Medical Center
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1890
mi
from 98109
Houston, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Baylor College of Medicine
1890
mi
from 98109
Houston, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1740
mi
from 98109
Temple, TX
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Scott & White Memorial Hospital
1740
mi
from 98109
Temple, TX
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
2316
mi
from 98109
Falls Church, VA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Inova Heart and Vascular Institute
2316
mi
from 98109
Falls Church, VA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1687
mi
from 98109
Milwaukee, WI
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Aurora St. Luke's Medical Center
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
682
mi
from 98109
San Francisco, CA
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
University of California at San Francisco
682
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1450
mi
from 98109
Rochester, MN
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
1717
mi
from 98109
St. Louis, MO
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Washington University School of Medicine
1717
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/19/2015
440
mi
from 98109
Calgary,
GS-4997 in Adults With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Study of GS-4997 in Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/19/2015
Alberta Health Services
440
mi
from 98109
Calgary,
Click here to add this to my saved trials
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated:  10/20/2015
2323
mi
from 98109
Baltimore, MD
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement: Continuous Intracranial Pressure Monitoring Subprotocol
Status: Enrolling
Updated: 10/20/2015
Sinai Hospital of Baltimore
2323
mi
from 98109
Baltimore, MD
Click here to add this to my saved trials
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated:  10/22/2015
2338
mi
from 98109
Durham, NC
Medication Adherence With Polyglot Meducation
Evaluate Changes in Medication Adherence and Patient Perspective of Polyglot Systems, Inc's Meducation Technology
Status: Enrolling
Updated: 10/22/2015
Durham VA Medical Center
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
1115
mi
from 98109
Phoenix, AZ
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Arizona Heart Rhythm Research Center
1115
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
962
mi
from 98109
Los Angeles, CA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University of Southern California
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
2322
mi
from 98109
Washington,
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
George Washington University
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
2547
mi
from 98109
Orlando, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Hospital and Cardiovascular Institute
2547
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
2526
mi
from 98109
Tampa, FL
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Florida Cardiovascular Institute
2526
mi
from 98109
Tampa, FL
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
2089
mi
from 98109
Houma, LA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiovascular Institute of the South
2089
mi
from 98109
Houma, LA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
1771
mi
from 98109
Petosky, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Cardiac and Vascular Research Center of Northern Michigan
1771
mi
from 98109
Petosky, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
1863
mi
from 98109
Saginaw, MI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Michigan Cardiovascular Institute
1863
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
873
mi
from 98109
Las Vegas, NV
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
University Medical Center of Southern Nevada
873
mi
from 98109
Las Vegas, NV
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
1516
mi
from 98109
Oklahoma City, OK
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Oklahoma Heart Hospital
1516
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
2131
mi
from 98109
Pittsburgh, PA
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Allegheny General Hospital
2131
mi
from 98109
Pittsburgh, PA
Click here to add this to my saved trials
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated:  10/26/2015
1558
mi
from 98109
Wausau, WI
CVRx Barostim Hypertension Pivotal Trial
CVRx Barostim Hypertension Pivotal Trial
Status: Enrolling
Updated: 10/26/2015
Aspirus Wausau Hospital
1558
mi
from 98109
Wausau, WI
Click here to add this to my saved trials
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated:  10/26/2015
2402
mi
from 98109
New York, NY
Combined Renin Inhibition/Beta-blockade
Renin System Responses to Combined Renin Inhibition and Beta Adrenergic Blockade
Status: Enrolling
Updated: 10/26/2015
The Rogosin Institute
2402
mi
from 98109
New York, NY
Click here to add this to my saved trials
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated:  11/3/2015
1811
mi
from 98109
W Lafayette, IN
Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese Adults
Effects of Milk Protein Concentrate on Blood Pressure, Inflammation, Muscle Health During Weight Loss in Overweight/Obese Adults
Status: Enrolling
Updated: 11/3/2015
Purdue University - Stone Hall 700 W State St
1811
mi
from 98109
W Lafayette, IN
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
2432
mi
from 98109
New Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Yale Cancer Center
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
1884
mi
from 98109
Houston, TX
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
University of Texas Health Science Center at Houston
1884
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
2431
mi
from 98109
West Haven, CT
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
VA Medical Center West Haven
2431
mi
from 98109
West Haven, CT
Click here to add this to my saved trials
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated:  11/3/2015
2485
mi
from 98109
Boston, MA
Pilot Study of Effect of Sorafenib on Portal Pressure
A Multi-Center, Placebo-Controlled Randomized Pilot of the Effect of Sorafenib on Portal Pressure in Patients With Cirrhosis, Portal Hypertension and Hepatocellular Carcinoma Treated With Ablative Therapy and/or Transarterial Chemoembolization
Status: Enrolling
Updated: 11/3/2015
Brigham and Women's
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials